THE HEALTH CARE INDUSTRY DOESN'T MAKE MONEY BY NOT TESTING:

"Across the U.S., there seems to be a lot of cancer screening in patients who have a short life expectancy," said lead researcher Dr. Ronald Chen, an assistant professor of radiation oncology at the University of North Carolina at Chapel Hill.

"For patients who have a limited life expectancy, cancer screening might cause them more harm than benefit," Chen said. "Most guidelines recommend that we stop screening for these cancers when the patient has a short life expectancy. There is no evidence that cancer screening helps patients who have less than 10 years to live."

Follow @brothersjudd